Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reinhold Cohn Group is an Israeli intellectual property consulting and legal services organization, not a biotech, pharma, or healthcare operating company. The group includes the patent attorneys firm Reinhold Cohn & Partners and the law firm Gilat, Bareket & Co., and provides services across patents, trademarks, designs, copyrights, licensing, due diligence, litigation, and broader IP strategy. It serves clients across many technical sectors, including life sciences, but it does not itself appear to develop therapeutic products or maintain a drug pipeline. For biotech analysts, the relevant takeaway is that this is an external IP advisory and legal services firm that may support life sciences companies on patent prosecution, freedom-to-operate, transactions, and enforcement matters.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reinhold Cohen & Co..